Mayne Pharma cannot access invoices from Cosette’s solicitors at Corrs Chambers Westgarth, with a judge saying he was not hopeful that they would help to resolve a costs fight related to litigation over their collapsed $672 million merger.
Shell’s Australian arm has succeeded in challenging a finding by the ATO that it needed to pay an additional $99 million in capital gains tax after it disposed of its 34.27 per cent holding in Woodside Petroleum.
At the centre of Tuesday night's budget are tax measures aimed at investment structures, negative gearing, and reforms to the capital gains perk that represent the biggest change to the taxation of Australian savings since 1999.
MinterEllison has denied an administrator’s claims that she was subjected to discrimination and repeated incidents of bullying, saying she frequently raised complaints about "innocuous" interactions with colleagues.
Trial in AstraZeneca's patent infringement case over Pharmacor's plans to launch a cheaper version of diabetes drug Forxiga has been delayed to October, after the generic drug maker got the all-clear to revise its cross-claim.
Criminals are increasingly using AI in their money laundering playbook, increasing the scale and sophistication of financial crimes, AUSTRAC has warned.
A former United Global Capital financial adviser who was banned from registering as financial adviser for two years has been hit with a three-year ban following an unsuccessful review to the Administrative Review Tribunal.
A former Mastercard business development director has admitted at trial to lying to the payments giant's finance department about the risk of 7-Eleven routing transactions to EFTPOS to seal a deal.
Supermarket giant Woolworths has been hit with a lawsuit by a former senior executive who claims she was forced to work up to 90 hours per week and was subjected to a "boys club" culture.